DOCSLIB.ORG

Clinical Immunology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical Immunology CLINICAL IMMUNOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 1521-6616 DESCRIPTION . Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor. Research Areas Include: • Ageing • Allergy • Autoimmunity • Biotechnology • Clinical Laboratory Immunology • HIV • Immunodermatology • Immunohematology • Immunotoxicology/Environmental • Infection and Immunity • Mucosal Immunity • Neuroimmunology • Primary Immunodeficiency • Transplantation • Tumor Immunology • Vaccines Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center AUDIENCE . Basic immunologists, researchers in clinical immunology, molecular biologists, cell biologists AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/yclim 1 IMPACT FACTOR . 2020: 3.969 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus SIIC Data Bases PubMed/Medline Biological Abstracts Chemical Abstracts Embase Current Contents - Life Sciences EDITORIAL BOARD . Editor-in-Chief C Tsokos, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, CLS-937, 02215, Boston, Massachusetts, United States of America Associate Editors J.S. Chou, Boston Children's Hospital, 02115, Boston, Massachusetts, United States of America M.A. Exley, The University of Manchester, M13 9PL, Manchester, United Kingdom S.J. Khoury, American University of Beirut, 1107 2020, Beirut, Lebanon A. La Cava, University of California Los Angeles, 90095, Los Angeles, California, United States of America L. J. Li, First Hospital of Zhejiang Province, 310003, Hangzhou, China Q. Lu, Second Xiangya Hospital Department of Dermatology, 410011, Changsha, Hunan, China K. Stephenson, Harvard Medical School, 02115, Boston, Massachusetts, United States of America D. Stroopinsky, Beth Israel Deaconess Medical Center, 02215, Boston, Massachusetts, United States of America B. M. Vonakis, Johns Hopkins University School of Medicine, 21205-2105, Baltimore, Maryland, United States of America X. Zhang, Chinese Academy of Medical Sciences & Peking Union Medical College, 100730, Beijing, China Editorial Board I. E. Adamopoulos, Boston, Massachusetts, United States of America T. Akimova, Philadelphia, Pennsylvania, United States of America D. Avigan, Boston, Massachusetts, United States of America H. Barouch, Boston, Massachusetts, United States of America J. Bergerson, Hamilton, Montana, United States of America E. Bergmann-Leitner, Silver Spring, Maryland, United States of America G. Bertsias, Irakleio, Greece R. Bhargava, Boston, Massachusetts, United States of America P.E. Bigazzi, Farmington, Connecticut, United States of America P. Blanco, Bordeaux, France S. Burastero, Milano, Italy R. Caricchio, Philadelphia, Pennsylvania, United States of America J. Chinen, Houston, Texas, United States of America D. Cihakova, Baltimore, Maryland, United States of America D. Comte, Lausanne, Switzerland J.C. Crispin, Ciudad de México, Mexico G.M. Deng, Wuhan, China H. Diao, Hangzhou, China W. Elyaman, New York, New York, United States of America L.G. Filion, Ottawa, Ontario, Canada S. Fleming, Manhattan, Kansas, United States of America S.-M. Fu, Richmond, Virginia, United States of America A. R Gennery, Newcastle Upon Tyne, United Kingdom C. M. Hedrich, Liverpool, United Kingdom M. G. von Herrath, La Jolla, California, United States of America M. Hirashima, Kagawa, Japan R. Hoyos, Santiago, Chile E. Janssen, Boston, Massachusetts, United States of America H. Kita, Rochester, Minnesota, United States of America AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/yclim 2 T. Koga, Nagasaki, Japan M. Kono, Sapporo, Japan V. C. Kyttaris, Boston, Massachusetts, United States of America H. Li, Boston, Massachusetts, United States of America S. N. C. Liossis, Patras, Greece M. Lo, Boston, Massachusetts, United States of America V. Lougaris, Brescia, Italy T. Mayadas, Boston, Massachusetts, United States of America M. Mizui, Suita, Japan K.D. Moudgil, Baltimore, Maryland, United States of America V. Moulton, Boston, Massachusetts, United States of America K.C. Nadeau, Stanford, California, United States of America H. Niu, Manhasset, New York, United States of America E. Oliver, Baltimore, Maryland, United States of America J. Orange, Philadelphia, Pennsylvania, United States of America M. Oukka, Seattle, Washington, United States of America A. Perl, Syracuse, New York, United States of America S. Pillai, Boston, Massachusetts, United States of America A. Psarras, London, United Kingdom T. Rauen S. Rosenzweig, Bethesda, Maryland, United States of America A. Satyam, Boston, Massachusetts, United States of America A. H. Sawalha, Pittsburgh, Pennsylvania, United States of America A. Sharabi N. Shen, Shanghai, China L.A. Spencer, Boston, Massachusetts, United States of America I. E. Stillman, Boston, Massachusetts, United States of America A. Suarez-Fueyo, Boston, Massachusetts, United States of America E. Svirchevskaya, Moskva, Russian Federation Y. Tanaka, Kitakyushu, Japan K. Tenbrock, Aachen, Germany B. Tsao, Los Angeles, California, United States of America M. Tsokos, Bethesda, Maryland, United States of America H.K. Wong S. Yasuda, Tokyo, Japan N. Yoshida, Boston, Massachusetts, United States of America T. Yoshida, Chuo-Ku, Japan C Yu, Columbus, Ohio, United States of America AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/yclim 3 GUIDE FOR AUTHORS . INTRODUCTION Clinical Immunology is an international medium devoted to publication of original investigations of the molecular and cellular basis of immunological diseases. Prospective contributors are encouraged to check recent articles published in Clinical Immunology on topics related to their manuscript to have a better understanding of the articles that the readership is interested in. Types of Articles Original Articles. The chief criteria for acceptance of papers submitted for publication are the originality, clarity, and quality of the work reported. In preparing an article for submission to Clinical Immunology, please be as concise as possible. Data should be presented clearly and without repetition. Where possible, refer to previously published material rather than including lengthy descriptions in the Materials and Methods section, combine tables or illustrations, and avoid repetition in the Introduction and Discussion sections. Reviews of 20 manuscript pages (double spaced or less, exclusive of references) are published monthly. Generally a maximum total of 4 figures/tables are included. Typically, they deal analytically with recent developments in basic, translational, and clinical interventional immunology of immediate interest to a broad range of clinical immunologists. Contributors are encouraged to contact Journal Article Publishing Support Hub, before undertaking a review in order to determine its suitability. Symposia-in-Writing. Periodically, the journal publishes a collection of brief state-of-the-art essays based on a single topic, accompanied by an introduction by the symposium's moderator. Potential moderators should contact the Editor-in-Chief or one of the Associate Editors. Brief articles describing and evaluating animal models of immune-mediated diseases of humans are published occasionally. Contributors should contact Journal Article Publishing Support Hub Rapid Communications (of no more than 3000 words and two tables and/or figures) will be considered for publication on an accelerated schedule. This category is NOT simply a place for short manuscripts but is reserved for papers that the authors feel will have unusually high impact and should be disseminated as soon as possible. The reasons for requesting a paper be considered as a Rapid Communication should be made clear in the cover letter. Rapid Communications will receive an expedited review, and reviewers will be requested to indicate only their recommendation for or against acceptance for publication, and the major reasons for this. Authors will be notified of their acceptability as early as possible. Once in production Rapid Communications will always be placed in the first available issue. Brief Communication (of no more than 3000 words and two tables and/or figures) will be considered for publication. This category is a place for short manuscripts that have important and generally conclusionary data on a specific issue. Letters to the Editor will be considered if they relate to articles published in the journal. They should be limited to 1000 words, contain no more than one figure or table, and should have no more than 10 citations. Editorials and Meeting Reports are published occasionally if they are directly relevant to the themes of the journal. Contact details for submission Articles for Clinical Immunology should be submitted via the journal's online submission and editorial system at https://www.editorialmanager.com/yclim/default.aspx. Customer support is available 24/7: Please use our help site at: https://service.elsevier.com/.
Load more

Recommended publications
  • CURRICULUM VITAE Floyd L
    CURRICULUM VITAE Floyd L. Wormley Jr., Ph.D. Office of Research and Graduate Studies Texas Christian University TCU Box 297024 Fort Worth, TX 76129 Phone: (817) 257-7104 ADDRESS: 7121 Axis Ct. Fort Worth, TX 76132 Tel: (817) 386-0645, E-mail: [email protected] ACADEMIC TRAINING: 2002-2005 Doctoral Fellowship, Infectious Diseases Duke University Medical Center, Durham, NC Interdisciplinary Research Training Program in AIDS Program in Microbial Pathogenesis of Cryptococcus neoformans Research Project: Study of host-pathogen interactions during Cryptococcus neoformans infection. Fellowship Advisor: John R. Perfect, M.D. 1998-2001 Doctor of Philosophy, Microbiology/Immunology Louisiana State University Health Sciences Center, New Orleans, LA Dissertation Title: Cell Mediated Immunity Against Experimental Candida albicans Vaginitis. Dissertation Advisor: Paul L. Fidel Jr., Ph.D. 1995-1998 Master of Science, Microbiology/Immunology Louisiana State University Health Sciences Center, New Orleans, LA Thesis Title: Evidence for a Unique CD4 Protein on Murine Vaginal CD4+ T Cells. Thesis Advisor: Paul L. Fidel Jr., Ph.D. 1990-1995 Bachelor of Science, Cellular and Molecular Biology Tulane University, New Orleans, LA. EMPLOYMENT: 2019-Present Associate Provost for Research and Dean of Graduate Studies, Texas Christian University, Fort Worth, TX Role and Responsibility – Promote the advancement of research within the institution and administer key compliance programs through which we promote the responsible conduct of research and integrity. I oversee all research policies and procedures, institutional research compliance committees, and research technology and innovation. I also oversee services and programs for those who seek financial support for their scholarly endeavors from inception of idea through submission and award of research/scholarly project.
    [Show full text]
  • Role of Infection and Immunity in Bovine Perinatal Mortality: Part 2
    animals Review Role of Infection and Immunity in Bovine Perinatal Mortality: Part 2. Fetomaternal Response to Infection and Novel Diagnostic Perspectives Paulina Jawor 1,* , John F. Mee 2 and Tadeusz Stefaniak 1 1 Department of Immunology, Pathophysiology and Veterinary Preventive Medicine, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland; [email protected] 2 Animal and Bioscience Research Department, Teagasc, Moorepark Research Centre, P61 P302 Fermoy, County Cork, Ireland; [email protected] * Correspondence: [email protected] Simple Summary: Bovine perinatal mortality (death of the fetus or calf before, during, or within 48 h of calving at full term (≥260 days) may be caused by noninfectious and infectious causes. Although infectious causes of fetal mortality are diagnosed less frequently, infection in utero may also compromise the development of the fetus without causing death. This review presents fetomaternal responses to infection and the changes which can be observed in such cases. Response to infection, especially the concentration of immunoglobulins and some acute-phase proteins, may be used for diagnostic purposes. Some changes in internal organs may also be used as an indicator of infection in utero. However, in all cases (except pathogen-specific antibody response) non-pathogen-specific responses do not aid in pathogen-specific diagnosis of the cause of calf death. But, nonspecific markers of in utero infection may allow us to assign the cause of fetal mortality to infection and thus Citation: Jawor, P.; Mee, J.F.; increase our overall diagnosis rate, particularly in cases of the “unexplained stillbirth”. Stefaniak, T. Role of Infection and Immunity in Bovine Perinatal Abstract: Bovine perinatal mortality due to infection may result either from the direct effects of Mortality: Part 2.
    [Show full text]
  • Mbio-2016-Casadevall-.Pdf
    Downloaded from EDITORIAL Rigorous Science: a How-To Guide mbio.asm.org Arturo Casadevall,a Founding Editor in Chief, mBio, Ferric C. Fang,b Editor in Chief, Infection and Immunity Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAa; Departments of Laboratory on January 3, 2017 - Published by Medicine and Microbiology, University of Washington School of Medicine, Seattle, Washington, USAb ABSTRACT Proposals to improve the reproducibility of biomedical research have emphasized scientific rigor. Although the word “rigor” is widely used, there has been little specific discussion as to what it means and how it can be achieved. We suggest that scientific rigor combines elements of mathematics, logic, philosophy, and ethics. We propose a framework for rigor that includes redundant experimental design, sound statistical analysis, recognition of error, avoidance of logical fallacies, and intel- lectual honesty. These elements lead to five actionable recommendations for research education. igor is a prized quality in scientific work. Although the term is ciple, such as Schrödinger’s cat or Maxwell’s demon in physics, or Rwidely used in both scientific and lay parlance, it has not been entirely experimental, as illustrated by Cavendish’s measurement precisely defined (1). Rigor has gained new prominence amid con- of the gravitational constant at the end of the 18th century. How- mbio.asm.org cerns about a lack of reproducibility in important studies (2, 3), an ever, in the biomedical sciences, most research has both theoreti- epidemic of retractions due to misconduct (4), and the discovery cal and experimental aspects. that the published literature is riddled with problematic images (5).
    [Show full text]
  • The 100 Top-Cited Tuberculosis Research Studies
    INT J TUBERC LUNG DIS 19(6):717–722 Q 2015 The Union http://dx.doi.org/10.5588/ijtld.14.0925 The 100 top-cited tuberculosis research studies L.-M. Chen,*† Y.-Q. Liu,* J.-N. Shen,* Y.-L. Peng,* T.-Y. Xiong,* X. Tong,‡ L. Du,*§¶ Y.-G. Zhang*§¶ *West China Hospital, West China Medical School, Sichuan University, Chengdu, †Department of Anaesthesiology, West China Hospital of Sichuan University, Chengdu, ‡Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, §The Periodical Press of West China Hospital, Sichuan University, Chengdu, ¶The Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu, China SUMMARY The examination of top-cited studies is a useful method ing author. The United States contributed the largest for identify and monitoring outstanding scientific number of studies, followed by the United Kingdom and research. The objective of this study was to identify France. The institutions with the largest number of and analyse the characteristics of the top 100 cited articles were the Institut National de la Santeetdela´ research studies on tuberculosis (TB) based on the Web Recherche Medicale´ in France and the University of of Knowledge. Overall, the top 100 cited studies were California in the United States. The studies appeared in cited between 366 and 4443 times, and were published 35 journals, with 11 published in Science, followed by between 1995 and 2010, with the largest number of PNAS and NEJM. The majority of TB articles have been publications in 2003 and in 1995. Four studies were published in those medical journals with the highest attributed to a single author and 10 to two authors; the impact factors, and are from the most industrialised number of authors exceeded six in 50 studies.
    [Show full text]
  • Infection and Immunity Volume 51 * January 1986 * Number 1 J
    INFECTION AND IMMUNITY VOLUME 51 * JANUARY 1986 * NUMBER 1 J. W. Shands, Jr., Editor in Chief (1989) University of Florida, Gainesville Phillip J. Baker, Editor (1990) Peter F. Bonventre, Editor (1989) Arthur G. Johnson, Editor (1986) National Institute ofAllergy and University of Cincinnati University of Minnesota, Duluth Infectious Diseases Cincinnati, Ohio Stephan E. Mergenhagen, Editor (1989) Bethesda, Md. Roy Curtiss III, Editor (1990) National Institute of Dental Researcl Edwin H. Beachey, Editor (1988) Washington University Bethesda, Md. VA Medical Center St. Louis, Mo. Memphis, Tenn. EDITORIAL BOARD Leonard C. Altman (1986) Toby K. Eisenstein (1987) F. Kierszenbaum (1987) Catherine Saelinger (1987) Michael A. Apicella (1988) Peter Elsbach (1986) Paul Kolenbrander (1986) Dwayne C. Savage (1987) Roland Arnold (1987) Stanley Falkow (1988) Julius P. Kreier (1986) Irving E. Salit (1986) John B. Bartlett (1988) John R. Finerty (1987) Maurice J. Lefford (1987) Charles F. Schachtele (1988) Joel B. Baseman (1988) Robert Fitzgerald (1986) Thomas Lehner (1986) Julius Schachter (1986) Robert E. Baughn (1987) James D. Folds (1988) Stephen H. Leppla (1988) Gary K. Schoolnik (1987) Gary K. Best (1988) Samuel B. Formal (1986) F. Y. Liew (1988) June R. Scott (1987) Jenefer Blackwell (1988) Peter Gemski (1988) Francis L. Macrina (1988) Philip Scott (1988) Arnold S. Bleiweis (1987) Robert Genco (1988) John Mansfield (1988) Alan Sher (1987) William H. Bowen (1988) Ronald J. Gibbons (1988) Jerry R. McGhee (1988) Gerald D. Shockman (1986) David E. Briles (1988) Emil Gotschlich (1988) Floyd C. McIntire (1988) W. A. Simpson (1988) Robert R. Brubaker (1986) Frank Griffin (1987) Monte Meltzer (1986) Phillip D. Smith (1988) Gerald Byrne (1988) Richard Guerrant (1986) Jiri Mestecky (1986) Ralph Snyderman (1988) Bruce Chassy (1987) Thomas L.
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 2.430 an Open Access Journal by MDPI Emerging Themes in Host–Pathogen Interactions and Host-Directed Therapies Guest Editors: Message from the Guest Editors Dr. Selvakumar Subbian The last decade has seen a surge in host-directed therapy Public Health Research Institute, for infectious diseases that improve host response to the New Jersey Medical School, Rutgers, The State University of pathogen, target virulence factors, activate the immune New Jersey, Newark, NJ, USA response, and reduce cell/tissue damage leading to [email protected] reduced mortality. Dr. Murugesan Rajaram With due recognition to developments and the importance Assistant Professor, Microbial of host–pathogen interactions and the rise in host-directed Infection and Immunity, Ohio therapy, the Editorial Board of the Medicina has decided to State University, columbus, OH, bring out a Special Issue on “Emerging Themes in Host– USA Pathogen Interactions and Host-Directed Therapies”. This [email protected] Special Issue will be jointly edited by Drs. Selvakumar Dr. Radha Gopalaswamy Subbian, Murugesan Rajaram and Radha Gopalaswamy. Biotechnologist, National We solicit research papers, short commentaries, and Reference Laboratory, reviews on all aspects of this subject area. Department of Bacteriology, National Institute for Research in Keywords: Infectious diseases; Host pathogen interactions; Tuberculosis, Chennai, India Microbial pathogenesis; Intracellular signalling; [email protected] Therapeutic agents; Repurposed drugs; Antibiotics; Immune response; Host-directed therapy; Vaccine; Infection; Virulence determinants Deadline for manuscript submissions: 22 October 2021 mdpi.com/si/56686 SpeciaIslsue IMPACT FACTOR 2.430 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof.
    [Show full text]
  • Virology Downunder, a Meeting Commentary from the 2019 Lorne Infection and Immunity Conference, Australia Gregor Ebert1,4, Prasad N
    Ebert et al. Virology Journal (2019) 16:109 https://doi.org/10.1186/s12985-019-1217-6 MEETINGREPORT Open Access Virology Downunder, a meeting commentary from the 2019 Lorne Infection and Immunity Conference, Australia Gregor Ebert1,4, Prasad N. Paradkar2 and Sarah L. Londrigan3* Abstract The aim of this article is to summarise the virology content presented at the 9th Lorne Infection and Immunity Conference, Australia, in February 2019. The broad program included virology as a key theme, and the commentary herein highlights several key virology presentations at the meeting. Keywords: Infection, Immunity, Inflammation, Pathogenesis Main text MERS, Marburg and Ebola viruses [1], but remarkably The Lorne Infection and Immunity Conference is one of are able to live asymptomatically with otherwise poten- five scientific meetings held during each month of tially lethal viruses [2]. Wang and colleagues are inter- February in seaside town of Lorne, on the Great Ocean ested in understanding the underlying immune mediated Road in Victoria (Australia). The specific aim of the regulatory mechanisms that facilitate a highly effective meeting is to bring together basic, clinical and transla- balance between viral defense and tolerance in bats as tional researchers - those who examine microbes and viral hosts. their impact on the innate or adaptive immune response, During their evolutionary adaption to effective flight, researchers who study the mechanisms that regulate bats not only developed elevated levels of basal alertness immune responses, and those who apply this knowledge reflected in increased metabolic heart rate and body to preventing and treating infectious and inflammatory temperature, they also seem to have evolved a highly diseases.
    [Show full text]
  • Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
    Downloaded from orbit.dtu.dk on: Jun 01, 2019 Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies Thakur, Aneesh; Mikkelsen Melvang, Heidi; Jungersen, Gregers Published in: Journal of Immunology Research Link to article, DOI: 10.1155/2019/1356540 Publication date: 2019 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Thakur, A., Mikkelsen Melvang, H., & Jungersen, G. (2019). Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies. Journal of Immunology Research, 2019, [1356540]. https://doi.org/10.1155/2019/1356540 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Hindawi Journal of Immunology Research Volume 2019, Article ID 1356540, 24 pages https://doi.org/10.1155/2019/1356540 Review Article Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies Aneesh Thakur ,1 Heidi Mikkelsen,2 and Gregers Jungersen 2,3 1Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark 2Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kemitorvet, 2800 Kgs.
    [Show full text]
  • Infection and Immunity Volume 57 * January 1989 * Number 1 J
    INFECTION AND IMMUNITY VOLUME 57 * JANUARY 1989 * NUMBER 1 J. W. Shands, Jr., Editor in Chief Dexter H. Howard, Editor (1991) (1989) University of California University of Florida, Gainesville Peter F. Bonventre, Editor (1989) Los Angeles, Calif. Phillip J. Baker, Editor (1990) University of Cincinnati Stephen H. Leppla, Editor (1991) National Institute of Allergy and Cincinnati, Ohio U.S. Army Medical Research Institute Infectious Diseases Roy Curtiss III, Editor (1990) ofInfectious Diseases Bethesda, Md. Washington University Frederick, Md. Edwin H. Beachey, Editor (1993) St. Louis, Mo. Stephan E. Mergenhagen, Editor (1989) VA Medical Center National Institute ofDental Research Memphis, Tenn. Bethesda, Md. EDITORIAL BOARD Soman N. Abraham (1991) Barry Eisenstein (1991) Suzanne M. Michalek (1989) Julius Schachter (1989) Julia Albright (1989) Joseph Ferretti (1989) Michael L. Misfeldt (1991) Stewart Scherer (1991) John F. Alderete (1991) Richard A. Finkelstein (1989) David C. Morrison (1989) Patrick Schlievert (1990) Leonard C. Altman (1989) Vincent A. Fischetti (1989) Steve L. Moseley (1990) June R. Scott (1990) Neil R. Baker (1989) David FitzGerald (1989) Antony J. Mukkada (1990) Thomas M. Shinnick (1991) Alan Barbour (1989) Robert Fitzgerald (1989) Robert S. Munford (1989) Gerald D. Shockman (1989) Joel B. Baseman- (1991) Ronald J. Gibbons (1991) Juneann W. Murphy (1990) W. A. Simpson (1991) Robert E. Baughn (1990) Jon Goguen (1989) H. Nikaido (1989) Emil Skamene (1991) Blaine L. Beaman (1991) William E. Goldman (1989) Staffan Normark (1991) Magie So (1989) Gary K. Best (1991) Emil Gotschlich (1991) Itzhak Ofek (1989) P. Frederick Sparling (1990) Jenefer Blackwell (1991) Frank M. Griffin, Jr. (1990) Dennis Ohman (1989) Susan Straley (1989) Arnold S.
    [Show full text]
  • Helen R. Whiteley, Chairman, Publicationsboard Walter G. Peter HI
    INFECTION AND IMMUNITY VOLUME 39 0 NUMBER 1 * JANUARY 1983 J. W. Shands, Jr., Editor-in-Chief (1984) University ofFlorida, Gainesville Phillip J. Baker, Editor (1985) Arthur G. Johnson, Editor (1986) National Institute ofAllergy andInfectious Diseases University of Minnesota, Duluth Bethesda, Md. Stephan E. Mergenhagen, Editor (1984) Peter F. Bonventre, Editor (1984) National Institute ofDental Research University of Cincinnati Bethesda, Md. Cincinnati, Ohio John H. Schwab, Editor (1985) Bernard N. Fields, Editor (1984) University ofNorth Carolina, Medical School Harvard University, Medical School Chapel Hill, N.C. Boston, Mass. EDITORIAL BOARD Michael A. Apicella (1985) Harry Greenberg (1985) Chik H. Pai (1985) John A. Armstrong (1983) Frank Griffin (1984) Monique Parant (1984) Roland Arnold (1984) Carlton L. Gyles (1985) Fred Rapp (1983) Joel B. Baseman (1985) Edgar Hanna (1984) John B. Robbins (1983) Edwin H. Beachey (1983) David Hentges (1985) Donald Robertson (1984) Elmer L. Becker (1984) Martin S. Hirach (1985) Burton Rosan (1983) Neil Backlow (1984) Randall K. Holmes (1983) Noel R. Rose (1983) Arnold S. Bledweis (1984) Dexter H. Howard (1985) Jon A. Rudbach (1984) William H. Bowen (1985) Howard M. JohnSon (1985) Stephen W. Russeil (1985) Robert R. Brubaker (1983) Karl M. Johnson (1983) R. Bradley Sack (1983) Ward Bullock, Jr. (1985) Russell C. Johnson (1985) Catherine Saelinger (1984) Priscilla A. Campbeil (1983) William Johnson (1985) Edward J. St. Martin (1985) Charles Carpenter (1985) Garth W. Jones (1984) Irvin E. Salit (1983) Bruce Chassy (1984) Irving G. Kagan (1983) Anthony J. Sbarra (1984) John 0. Cisar (1985) Dennis L. Kasper (1985) Charles F. Schachtele (1985) John Clements (1985) George E.
    [Show full text]
  • Download the ASM Journals 2020 Media
    2020 Media Kit The American Society for Microbiology (ASM) is among the largest single life membership organizations in the world. Membership has grown from 59 scientists in 1899 to more than 30,000 members today, with more than one third located outside the United States. The mission of the ASM is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. ASM Journals continue to advance the life sciences by disseminating top fundamental and applied research to scientists around the globe. Table of Contents Contacts ASM Journals ................................................1 Publishing office Advertising sales office American Society for Microbiology The Walchli Tauber Group, Inc. Website advertising ................................... 2 1752 N Street, NW 2225 Old Emmorton Road, Suite 201 ASM Journals ....................................... 2 Washington, DC 20036 Bel Air, MD 21015 ASM Science ........................................ 3 (202) 737-3600 Tel (443) 512-8899 Email advertising........................................ 4 www.asm.org Fax (443) 512-8909 ASM Journals ....................................... 4 www.wt-group.com Member data ............................................. 4 Kelley Russell Advertising policies .................................... 6 Sales Manager, ASM (214) 704-4628 [email protected] ASM Journals There are now 13 unique journals to target advertising to the largest single life science membership in the world... ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology. With over 90 years of experience, ASM journals continue to be an authoritative source for the latest in microbiology research. ASM reserves the right to approve all ad creatives which will run on any ASM websites and emails.
    [Show full text]
  • ASM Journals Eliminate Impact Factor Information from Journal Websites
    crossmark EDITORIAL ASM Journals Eliminate Impact Factor Information from Journal Websites Arturo Casadevall,a Editor in Chief, mBio®, Stefano Bertuzzi,b Chief Executive Officer, ASM, Michael J. Buchmeier,c Editor in Chief, Microbiology and Molecular Biology Reviews®, Roger J. Davis,d Editor in Chief, Molecular and Cellular Biology®, Harold Drake,e Editor in Chief, Applied and Environmental Microbiology®, Ferric C. Fang,f Editor in Chief, Infection and Immunity®, Jack Gilbert,g Editor in Chief, mSystems™, Barbara M. Goldman,b Director, Journals, ASM, Michael J. Imperiale,h Editor in Chief, mSphere™, Philip Matsumura,i Editor, Genome Announcements™, Alexander J. McAdam,j Editor in Chief, Journal of Clinical Microbiology®, Marcela F. Pasetti,k Editor in Chief, Clinical and Vaccine Immunology®, Rozanne M. Sandri-Goldin,l Editor in Chief, Journal of Virology®, Thomas Silhavy,m Editor in Chief, Journal of Bacteriology®, Louis Rice,n Editor in Chief, Antimicrobial Agents and Chemotherapy®, Jo-Anne H. Young,o Editor in Chief, Clinical Microbiology Reviews®, Thomas Shenk,m Chair, Publications Board, ASM Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAa; American Society for Microbiology (ASM), Washington, DC, USAb; Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California, USAc; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA, and Program in Molecular Medicine, University of Massachusetts Medical School, Worcester,
    [Show full text]